NEW YORK – PreludeDx announced on Monday that it has partnered with cancer care provider GenesisCare to expand access to its DCISionRT precision medicine test for women with breast cancer.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.